Fonte: British Journal of Ophthalmology. Unidade: FM
Assuntos: TOMOGRAFIA DE COERÊNCIA ÓPTICA, ESTUDOS RANDOMIZADOS, EDEMA MACULAR CISTOIDE, FACOEMULSIFICAÇÃO
ABNT
TZELIKIS, Patrick Frensel et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study. British Journal of Ophthalmology, v. 99, n. 5, p. 654-658, 2015Tradução . . Disponível em: https://doi.org/10.1136/bjophthalmol-2015-306989. Acesso em: 31 ago. 2024.APA
Tzelikis, P. F., Vieira, M., Hida, W. T., Motta, A. F., Nakano, C. T., Nakano, E. M., & Alves, M. R. (2015). Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study. British Journal of Ophthalmology, 99( 5), 654-658. doi:10.1136/bjophthalmol-2015-306989NLM
Tzelikis PF, Vieira M, Hida WT, Motta AF, Nakano CT, Nakano EM, Alves MR. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study [Internet]. British Journal of Ophthalmology. 2015 ; 99( 5): 654-658.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1136/bjophthalmol-2015-306989Vancouver
Tzelikis PF, Vieira M, Hida WT, Motta AF, Nakano CT, Nakano EM, Alves MR. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study [Internet]. British Journal of Ophthalmology. 2015 ; 99( 5): 654-658.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1136/bjophthalmol-2015-306989